Abstract
IntroductionB-cell Non-Hodgkin lymphomas (B-NHLs) include a number of disease subtypes, each defined by the tempo of disease progression and the identity of the cancerous cell. Idelalisib is a pote...
Funding Information
  • Fred Hutchinson Cancer Center (P30 CA015704)
  • National Institutes of Health (5T32HL007093, K24CA184039, P01CA44991)

This publication has 61 references indexed in Scilit: